These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2793245)

  • 21. Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.
    Chang HL; Gillett N; Figari I; Lopez AR; Palladino MA; Derynck R
    Cancer Res; 1993 Sep; 53(18):4391-8. PubMed ID: 8364935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo.
    Busund LT; Killie MK; Bartnes K; Seljelid R
    Int J Cancer; 2003 Aug; 106(2):153-9. PubMed ID: 12800188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythroid cell fusion in the early phase of Friend virus leukemogenesis.
    Behringer RR; LoCascio NJ; Dewey MJ
    J Natl Cancer Inst; 1987 Sep; 79(3):601-3. PubMed ID: 3476795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME; Roopenian DC
    J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trophoblast giant cell differentiation in the mouse: expression of glucose phosphate isomerase (GPI-1) electrophoretic variants in transferred and chimeric embryos.
    Chapman VM; Ansell JD; McLaren A
    Dev Biol; 1972 Sep; 29(1):48-54. PubMed ID: 5074213
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1967 Jul; 27(7):1243-7. PubMed ID: 4952516
    [No Abstract]   [Full Text] [Related]  

  • 28. Chromosomal changes in 20-methylcholanthrene induced sarcomas in mice in relation to time of appearance of the tumours.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):1-7. PubMed ID: 4982322
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
    Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
    J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple antigenic specificities within primary 3-methylcholanthrene-induced rat sarcomas and metastases.
    Pimm MV; Embleton MJ; Baldwin RW
    Int J Cancer; 1980 May; 25(5):621-9. PubMed ID: 6154664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
    Parker GA; Rosenberg SA
    J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukemoid reaction in BALB/c mice bearing primary tumors induced by 3-methylcholanthrene.
    Kodama T; Kawamura T; Kobayashi H
    Cancer Res; 1978 Mar; 38(3):713-5. PubMed ID: 626975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
    Ustinov AS; Lavrovskiĭ VA
    Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
    Kumar V; Bennett M
    J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current topics on tumor immunology].
    Tachibana T
    Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation and neoplastic development of hamster chondrocytes after exposure to 4-nitroquinoline-1-oxide and 3-methylcholanthrene in tissue culture.
    Katoh Y
    J Natl Cancer Inst; 1977 Jul; 59(1):155-63. PubMed ID: 406412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro malignant transformation by methylcholanthrene of the progeny of single cells derived from C3H mouse prostate.
    Mondal S; Heidelberger C
    Proc Natl Acad Sci U S A; 1970 Jan; 65(1):219-25. PubMed ID: 5263752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association in the expression of Kirsten-ras oncogene and the major histocompatibility complex class I antigens in fibrosarcoma tumor cell variants exhibiting different metastatic capabilities.
    Alon Y; Hammerling GJ; Segal S; Bar-Eli M
    Cancer Res; 1987 May; 47(10):2553-7. PubMed ID: 3552201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.